SAM
SMMT icon

Sectoral Asset Management’s Summit Therapeutics SMMT Stock Holding History

Sectoral Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
220,180
+150,565
+216% +$2.67M 2.24% 12
2026
Q1 		$1.4M Sell
69,615
-10,010
-13% -$162K 1.16% 24
2025
Q4 		$1.39M Buy
79,625
+5,555
+7% +$105K 1.12% 27
2025
Q3 		$1.53M Buy
74,070
+8,850
+14% +$215K 0.94% 38
2025
Q2 		$1.39M Sell
65,220
-4,020
-6% -$91.7K 0.92% 40
2025
Q1 		$1.34M Buy
69,240
+39,240
+131% +$787K 1.04% 26
2024
Q4 		$535K Buy
30,000
+3,300
+12% +$64K 0.36% 55
2024
Q3 		$585K Buy
26,700
+1,700
+7% +$23.8K 0.35% 63
2024
Q2 		$195K Sell
25,000
-290,000
-92% -$1.57M 0.08% 89
2024
Q1 		$1.3M Buy
315,000
+285,000
+950% +$1.13M 0.51% 56
2023
Q4 		$78.3K Buy
30,000
+10,000
+50% +$20.6K 0.03% 104
2023
Q3 		$37.4K Sell
20,000
-30,000
-60% -$57.2K 0.01% 122
2023
Q2 		$126K Buy
50,000
+30,000
+150% +$54.8K 0.02% 121
2023
Q1 		$35K Buy
+20,000
New +$54.5K 0.01% 118

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sectoral Asset Management's SMMT Position: Q2 2026 in Review

Sectoral Asset Management increased its Summit Therapeutics (SMMT) stake by 216% in Q2 2026, buying an estimated $2.67M and bringing the position to 220,180 shares worth $3.21M. The position accounts for 2.24% of the portfolio, ranked #12.

Sectoral Asset Management first reported a position in SMMT in Q1 2023 and has held it in 14 quarters since. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Sectoral Asset Management held 220,180 shares of Summit Therapeutics worth $3.21M as of Q2 2026.
  • Sectoral Asset Management bought 150,565 Summit Therapeutics shares in Q2 2026, an estimated $2.67M.
  • Summit Therapeutics made up 2.24% of Sectoral Asset Management's portfolio in Q2 2026, its #12 holding.
  • Sectoral Asset Management first reported a position in Summit Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.